Enfuvirtide Subcutaneous and Insulin glargine
Determining the interaction of Enfuvirtide Subcutaneous and Insulin glargine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: enfuvirtide
Brand name: Fuzeon
Synonyms: Enfuvirtide
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Enfuvirtide Subcutaneous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Enfuvirtide Subcutaneous-Insulin Glargine (U-100) Vials
- Enfuvirtide Subcutaneous-Insulin Glargine (U-300) Pens
- Enfuvirtide Subcutaneous-Insulin glargine and lixisenatide
- Enfuvirtide Subcutaneous-Insulin glargine and lixisenatide Subcutaneous
- Enfuvirtide Subcutaneous-Insulin glargine, recombinant Subcutaneous
- Insulin glargine-Engerix-B
- Insulin glargine-Engerix-B Pediatric
- Insulin glargine-Enjuvia
- Insulin glargine-Enjuvia Oral
- Insulin glargine-Enlon
- Insulin glargine-Enlon-Plus